Gevo Inc. (GEVO) — RQD Stock Rating Cockpit

$1.25 +3.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.26

Gevo Inc. (GEVO) carries a Roarable Rating of E (Strong Sell) with 26/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $309.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on GEVO Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is GEVO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Gevo Inc. (NASDAQ: GEVO) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $1.25 (+3.31% 1D, market cap $309.0M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, GEVO ranks #252 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does GEVO compare to ASPI and OEC in the Materials sector?
▼

Within the Materials sector (Major Chemicals), GEVO carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -2.9%. By comparison, ASPI (ASP Isotopes Inc.) holds a E grade (21/100 RQD, P/E N/A, ROIC -35.0%, cap $309.7M) and OEC (Orion S.A.) posts a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $316.5M). Among the 5-stock peer group, GEVO leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for GEVO?
▼

Per GEVO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001392380), Gevo Inc. generated $160.6M in revenue (+849.3% YoY), -$33.8M in net income, and -$43.5M in free cash flow against $718.9M in total assets and $164.8M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.26 (+0.41%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (26/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510026
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Cash (4)Whales (5)SEC (8)Macro (6)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-14.4% Base Target
$3 Bull$1 Base$1 Bear
📬 FREE GEVO RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GEVO)Realized 20D OHLCV Swing Band: ±10.9%
Deterministic 5-Pillar Attribution (26/100 Composite)
🔍 WHY GEVO SCORES 26/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (31% of score)

Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Macro Regime Fit+6/20 pts (23% of score)

FRED Regime × Technicals: 9% of 52W Range • RSI-14 at 48.9 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
34
Grade E$1.29-12.4% Next Q
Q2 (-2Q)
31
Grade E$1.13+3.5% Next Q
Q3 (-1Q)
29
Grade E$1.17+6.8% Next Q
Current
26
Grade E$1.25-10.5% Hist 90D α
Trajectory: E (34) → E (26)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a GEVO Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While GEVO currently carries a cautious 26/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Materials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.40) and Max Pain ($1.31) forces dealer call-delta covering toward $3.12.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $GEVO• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “GEVO Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
48.930 Oversold · 70 Hot
ALTMAN-Z SHIELDDISTRESS RISK (<1.8)
0.20>3.0 Fortress Safe
PIOTROSKI F-SCORESOLID CORE (5–6)
5 / 99-Pt Accounting
52-WEEK LASER RANGE9% OF RANGE
L: $1$1.25H: $3
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 4 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 8 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D-RQD 14 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on GEVO

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (20)

-2.9% ROIC with 42.0% gross margin and -14.55% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (40)

Altman-Z 0.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (23)

8/40 institutional & smart-money positioning score with 6/20 macro alignment.

Bull Case: Why Buyers Like GEVO
  • ✓Established market leader in Materials with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GEVO)

  • ✓Walkthrough of GEVO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
GEVO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -39.61%▼ DESCENDING CHANNEL
2026-11-03O $1.21H $1.25L $1.21C $1.25VOL 2.97M
RES: $1.73SUP: $1.02SMA50: $1.40SMA200: $1.71
$2.25$1.93$1.62$1.31$0.99RES $1.73SUP $1.02$1.252026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

GEVO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on GEVO today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for GEVO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for GEVO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GEVO)

Materials Rank #252 of 270 ⚔️ ASPI vs GEVO Full Matrix →

1. Head-to-Head Materials Peer Comparison (GEVO vs. ASPI, OEC, ALTO, NL)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Gevo Inc. (GEVO) ranks #252 by composite RQD confidence (26/100, grade E) and #198 by equity capitalization ($309.0M). Within this direct 5-issuer industry benchmark cohort, GEVO leads on earnings valuation at N/A trailing P/E, while NL leads on capital efficiency and profitability with 3.4% ROIC and 30.4% gross margin. ALTO currently holds the highest overall quantitative score in the immediate peer group at 46/100 (D) compared with GEVO at 26/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
GEVO ACTIVE
Gevo Inc.
E 26/100 — — -2.9% +3.31% $309.0M Benchmark Subject
ASPI
ASP Isotopes Inc.
E 21/100 — 14.3% -35.0% -5.16% $309.7M /aspi-vs-gevo →
OEC
Orion S.A.
D- 39/100 — 19.9% 2.2% +1.08% $316.5M /oec-vs-gevo →
ALTO
Alto Ingredients Inc.
D 46/100 — 3.8% 2.0% 0.00% $283.1M /alto-vs-gevo →
NL
NLI Holdings Inc.
D 46/100 — 30.4% 3.4% +1.72% $347.7M /nl-vs-gevo →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001392380

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Gevo Inc. (GEVO) reported GAAP revenue of $160.6M (+849.3% vs. FY2024 revenue of $16.9M , and +833.6% cumulative change since FY2023) , GAAP net income of -$33.8M, operating cash flow of -$13.4M, and free cash flow of -$43.5M (+59.9% YoY). On the balance sheet, GEVO closed FY2025 with $718.9M in total assets against $164.8M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $160.6M -$33.8M -$13.4M -$43.5M $718.9M $164.8M
FY2024 (FY) 2024-12-31 $16.9M -$78.6M -$57.4M -$108.5M $583.9M $67.1M
FY2023 (FY) 2023-12-31 $17.2M -$66.2M -$53.7M -$53.7M — —

3. GEVO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is GEVO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Gevo Inc. (NASDAQ: GEVO) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $1.25 (+3.31% 1D, market cap $309.0M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, GEVO ranks #252 in composite RQD confidence.

How does GEVO compare to ASPI and OEC in the Materials sector?

Within the Materials sector (Major Chemicals), GEVO carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -2.9%. By comparison, ASPI (ASP Isotopes Inc.) holds a E grade (21/100 RQD, P/E N/A, ROIC -35.0%, cap $309.7M) and OEC (Orion S.A.) posts a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $316.5M). Among the 5-stock peer group, GEVO leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for GEVO?

Per GEVO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001392380), Gevo Inc. generated $160.6M in revenue (+849.3% YoY), -$33.8M in net income, and -$43.5M in free cash flow against $718.9M in total assets and $164.8M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is GEVO trading relative to its 50-day, 200-day, and 52-week technical levels?

GEVO last traded at $1.25 (+3.31% on volume of 2,969,356 shares), positioning the stock -10.71% below its 50-day simple moving average ($1.40) and -26.90% below its 200-day simple moving average ($1.71). Across its 52-week range of $1.09 to $2.97, GEVO sits at the 8.5% percentile with a 14-day RSI of 48.9 (NEUTRAL RANGE) and an implied next-earnings move of ±10.9% ($1.11 to $1.39).

GEVO Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell GEVO stock right now?

Gevo Inc. (GEVO) currently earns a Roarable Rating of E (Strong Sell — SELL) with 26/100 RQD Confidence. Stretched risk/reward at current multiples (-3% return on capital) under elevated 10-year interest-rate pressure.

What is GEVO's 12-month price target and RQD AI Jury consensus?

GEVO's 12-month base price target is $1.07 (range $0.83 to $3.12), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

ROARABLE RATING BRIEF • RQD 26/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

GEVO — Gevo Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:38:48Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, GEVO scores 24 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are: Fundamental Cash Engine at 4/20 (ROIC -2.9%; FCF yield -14.55%), Whale 13F Flow at 3/20 (institutional accumulation and options positioning), Insider Conviction at 3/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 6/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 8/20 (Altman Z 0.2; Piotroski F 5/9; Debt/Equity 0.35).

Investor implication: the weakest pillars are the cash engine and the ownership-flow signals, meaning the business is not currently converting capital into positive returns or free cash, and the rating system finds little evidence of conviction from insiders or large institutions. The balance sheet pillar scores somewhat higher than the others, but an Altman Z of 0.2 sits in a range the rating treats as distress-adjacent, so the modest score reflects forensic caution rather than comfort. A prospective investor would need to weigh any upside narrative against negative free cash flow and an unfavorable forensic profile. The verdict is a quantitative screen output, not a recommendation.

Business

Gevo Inc. is a NASDAQ-listed issuer classified in the Materials sector and Major Chemicals industry, per the profile section. The source data does not describe its products, customers, or revenue model. The reported revenue figures and carbon removal credit sales referenced in the news wire indicate the company generates revenue from carbon-related credit transactions, but the source data does not further detail its business lines or how it monetizes them.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$160.6M$-20.2M$-33.8MN/A$-43.5M$81.2M$164.8M
FY 2024$16.9M$-90.8M$-78.6MN/A$-108.5M$189.4M$67.1M
FY 2023$17.2M$-81.8M$-66.2MN/A$-53.7MN/AN/A

Per the SEC financials, the company reported net losses in all three periods, with FY 2025 revenue rising sharply to $160.6M from $16.9M in FY 2024, while operating and net losses narrowed. Per the market data, the operating margin is -12.6%, net margin -21.1%, gross margin 0%, and ROIC -2.9%. Per the Roarable RQD rating, the Altman Z-Score is 0.2, the Piotroski F-Score is 5/9, and Debt/Equity is 0.35. Cash fell from $189.4M to $81.2M while debt rose from $67.1M to $164.8M across the two most recent reported years.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts section, the wire contains six items, all related to GEVO, with light signals of mostly YELLOW (market wire) and one GREEN catalyst. The headlines cover a stock move reported as trading up, a price target maintained at $14 by H.C. Wainwright, a sale of 10,000 carbon removal credits with the stock gaining 5%, and several general quote and forecast pages. The only item tagged as a catalyst is the carbon credit sale. The price target headline stands out against the $1.21 price in market data, but the source does not provide the basis for the target. The butterfly supply-chain graph reports no supply-chain links and no proprietary signals.

Open Questions

  • What is the company's product mix and what share of FY 2025 revenue comes from carbon credit sales versus other activities?
  • Why did cash decline by roughly $108M between FY 2024 and FY 2025 and how is the company funding operating losses?
  • What is the basis for the $14 price target referenced in the news wire, given the $1.21 price?
  • What are the debt maturities and covenant terms behind the increase in debt to $164.8M?
  • What drove the swing from $16.9M to $160.6M in revenue, and is that revenue recurring?

GEVO Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Gevo Inc. (GEVO) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to GEVO Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

GEVO Bull vs. Bear Conversation Board — What's Your Call at $1.25?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON GEVO 🐻 67% BEARISH CONVICTION
1. Pick Your Side on GEVO:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.06 (-12.4%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is GEVO (E • RQD 24/100) a Buy at $1.21?

Welcome to the GEVO (Gevo Inc.) Roar Pit. Current RQD Composite is 24/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.02 (-15.7%)
Spot @ $1.21

Pump the brakes on GEVO — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on GEVO, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Gevo Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.44 (+19.0%)
Spot @ $1.21

GEVO cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on GEVO, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $1.21 (52-wk range $1.09 - $2.97), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%